UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K/A

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 20, 2017 (September 1, 2017)

 

 

GENESIS ENERGY, L.P.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   1-12295   76-0513049

(State or other jurisdiction

of incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

919 Milam, Suite 2100, Houston, Texas   77002
(Address of principal executive offices)   (Zip Code)

(713) 860-2500

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐  Emerging growth company

☐  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


EXPLANATORY NOTE

As reported in a Current Report on Form 8-K filed by Genesis Energy, L.P. (“Genesis”) on September 7, 2017 (the “Original 8-K”), Genesis completed the closing of the transaction contemplated by the stock purchase agreement dated August 2, 2017 among Genesis, Tronox US Holdings, Tronox Alkali Corporation (“Alkali”) and, for the purposes set forth therein, Tronox Limited (“Tronox”). At the closing, Genesis purchased Tronox’s trona and trona-based exploring, mining, processing, producing, marketing and selling business through the acquisition of 100% of the equity interests in Alkali, a subsidiary of Tronox. This Amendment No. 1 is being filed to amend Item 9.01 of the Original 8-K to include financial statements and pro forma financial information required by Item 9.01 of Form 8-K. The remainder of the information contained in the Original 8-K is not hereby amended.

Item 9.01. Financial Statements and Exhibits

(a)     Financial Statements of Businesses Acquired.

The unaudited combined financial statements of the Alkali Chemicals Business of Tronox Limited as of June 30, 2017 and for the three and six months ended June 30, 2017 and 2016 and the notes thereto are filed as Exhibit 99.2 to this Current Report on Form 8-K/A and are incorporated into this Item 9.01 by reference.

The audited combined financial statements of the Alkali Chemicals Business of Tronox Limited as of December 31, 2016 and 2015 and for the year ended December 31, 2016 (Successor) and for the nine month period ended December 31, 2015 (Successor) and for the three month period ended March 31, 2015 (Predecessor) and the notes thereto, together with the report of PricewaterhouseCoopers LLP, independent auditors, with respect to the balance sheets as of December 31, 2016 and 2015, and the related statements of operations, comprehensive income, cash flows and changes in parent company equity for the year ended December 31, 2016 and the period from April 1, 2015 through December 31, 2015, and the report of RSM US LLP, independent auditors, with respect to the combined balance sheet as of March 31, 2015, the related combined statement of operations, combined statement of comprehensive income, combined statement of changes in parent equity and combined statement of cash flows for the period from January 1, 2015 through March 31, 2015, a copy of which is incorporated by reference as Exhibit 99.3 to this Current Report on Form 8-K and is incorporated into this Item 9.01 by reference.

(b)     Pro Forma Financial Information .

The unaudited pro forma condensed combined consolidated financial information of Genesis as of and for the six months ended June 30, 2017 and for the year ended December 31, 2016, are filed as Exhibit 99.4 to this Current Report on Form 8-K/A and are incorporated into this Item 9.01 by reference.

(c) Exhibits

The following materials are filed as exhibits to this Current Report on Form 8-K/A.

Exhibits .

 

23.1   Consent of PricewaterhouseCoopers LLP, independent auditors (Alkali Chemicals Business of Tronox Limited).
23.2   Consent of RSM US LLP, independent auditors (Alkali Chemicals Business of Tronox Limited).
99.2   Unaudited financial statements of Alkali Chemicals Business of Tronox Limited as of June 30, 2017 and for the three and six months ended June 30, 2017 and 2016 and the notes thereto.
99.3   Audited financial statements of Alkali Chemicals Business of Tronox Limited as of December  31, 2016 and 2015 and for each of the years ended December 31, 2016 (Successor) and for the nine month period ended December 31, 2015 (Successor) and for the three month period ended March  31, 2015 (Predecessor) and the notes thereto (incorporated by reference to Exhibit 99.5 to Form 8-K dated August 7, 2017, File No. 001-12295).
99.4   Unaudited pro forma condensed combined consolidated financial information of Genesis as of and for the six months ended June 30, 2017 and for the year ended December 31, 2016.
 
 

 

-2-


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     

GENESIS ENERGY, L.P.

(A Delaware Limited Partnership)

    By:   GENESIS ENERGY, LLC., as its sole general partner
Date: September 20, 2017     By:  

/s/ R OBERT V. D EERE

     

Robert V. Deere

Chief Financial Officer

Exhibit 23.1

CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-203259, No. 333-173337, No. 333-150239, No. 333-195858, No. 333-219710) and on Form S-8 (No. 333-156084) of Genesis Energy, L.P. of our report dated March 31, 2017, except for the effects of the revision discussed in Note 20 to the combined financial statements, as to which the date is August 2, 2017, relating to the financial statements of the Alkali Chemicals Business, which is incorporated by reference to Exhibit 99.5 to Form 8-K dated August 7, 2017, File No. 001-12295 of Genesis Energy, L.P.

/s/ PricewaterhouseCoopers LLP

Philadelphia, PA

September 20, 2017

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Form 8-K of Genesis Energy, L.P. of our report dated March 31, 2017, relating to the combined financial statements of Alkali Chemicals Business (A Business of Tronox Limited) as of and for the three months ended March 31, 2015 and to incorporation by reference in Registration Statement No. 333-203259, Registration Statement No. 333-173337, Registration Statement No. 333-150239, Registration Statement No. 333-195858, and Registration Statement No. 333-219710 on Form S-3 and in Registration Statement No. 333-156084 on Form S-8.

/s/ RSM US LLP

Stamford, Connecticut

September 20, 2017

Exhibit 99.2

Alkali Chemicals Business

(A Business of Tronox Limited)

Interim Condensed Combined Financial Statements

for the Three Months Ended June 30, 2017 and 2016 (Unaudited) and the Six Months Ended June 30, 2017 and 2016 (Unaudited)


Alkali Chemicals Business

(A Business of Tronox Limited)

INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

Table of Contents

 

     Page No.  

Interim Condensed Combined Statements of Operations (Unaudited) for the Three and Six Months Ended June 30, 2017 and 2016

     2  

Interim Condensed Combined Statements of Comprehensive Income (Unaudited) for the Three and Six Months Ended June 30, 2017 and 2016

     3  

Interim Condensed Combined Balance Sheets (Unaudited) at June 30, 2017 and December 31, 2016

     4  

Interim Condensed Combined Statements of Changes in Parent Company Net Investment (Unaudited) for the Six Months Ended June 30, 2017

     5  

Interim Condensed Combined Statements of Cash Flows (Unaudited) for the Six Months Ended June 30, 2017 and 2016

     6  

Notes to Interim Condensed Combined Financial Statements (Unaudited)

     7  

 

1


Alkali Chemicals Business

(A Business of Tronox Limited)

INTERIM CONDENSED COMBINED STATEMENTS OF OPERATIONS (Unaudited)

(In millions)

 

     Three months
ended

June 30, 2017
    Three months
ended

June 30, 2016
    Six months
ended

June 30, 2017
    Six months
ended

June 30, 2016
 

Net Sales

   $ 201.3     $ 204.8     $ 391.9     $ 394.8  

Cost of goods sold

     (172.3     (183.9     (335.0     (347.5
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit

     29.0       20.9       56.9       47.3  

Selling, general and administrative expenses

     (9.8     (11.9     (20.6     (20.9

Restructuring expense

     —         —         (1.2     —    

Research and development expenses

     (0.3     (0.7     (0.5     (1.0
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations before income taxes

     18.9       8.3       34.6       25.4  

Income tax

     (8.0     (3.4     (14.4     (10.5
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 10.9     $ 4.9     $ 20.2     $ 14.9  
  

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these Interim Condensed Combined Financial Statements.

 

2


Alkali Chemicals Business

(A Business of Tronox Limited)

INTERIM CONDENSED COMBINED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In millions)

 

    Three months
ended

June 30, 2017
    Three months
ended

June 30, 2016
    Six months
ended

June 30, 2017
    Six months
ended

June 30, 2016
 

Net income

  $ 10.9     $ 4.9     $ 20.2     $ 14.9  

Other comprehensive (loss) income, net of tax:

       

Unrealized (losses) gains on derivatives, net of taxes of $0.2 and $(0.7) for the three months ended June 30, 2017 and June 30, 2016, respectively and $1.1 and $(0.7) for the six months ended June 30, 2017 and June 30, 2016, respectively

    (0.4     1.1       (1.9     1.1  

Unrecognized prior service (cost)/credit, net of taxes of $(0.1) and nill for the three months ended June 30, 2017 and June 30, 2016, respectively and $(0.1) and nill for the six months ended June 30, 2017 and June 30, 2016, respectively

    0.2       —         0.2       —    
 

 

 

   

 

 

   

 

 

   

 

 

 

Total other comprehensive (loss) income

    (0.2     1.1       (1.7     1.1  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net comprehensive income

  $ 10.7     $ 6.0     $ 18.5     $ 16.0  
 

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these Interim Condensed Combined Financial Statements.

 

3


Alkali Chemicals Business

(A Business of Tronox Limited)

INTERIM CONDENSED COMBINED BALANCE SHEETS (Unaudited)

(In millions)

 

     As of
June 30, 2017
    As of
December 31, 2016
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 10.6     $ 37.2  

Trade receivables, net of allowance for doubtful accounts

     84.2       84.9  

Receivables from related parties and affiliates, net

     53.3       60.0  

Inventories, net

     35.3       33.7  

Prepaid and other assets

     14.7       20.8  
  

 

 

   

 

 

 

Total current assets

     198.1       236.6  

Noncurrent assets :

    

Property, plant and equipment, net

     721.7       738.0  

Mineral leaseholds, net

     726.6       729.2  

Other long-term assets

     4.2       3.2  
  

 

 

   

 

 

 

Total assets

   $ 1,650.6     $ 1,707.0  
  

 

 

   

 

 

 

LIABILITIES AND EQUITY

    

Current liabilities:

    

Accounts payable, trade and other

   $ 53.2     $ 47.5  

Net due to parent

     4.8       13.4  

Accrued liabilities

     25.7       32.1  
  

 

 

   

 

 

 

Total current liabilities

     83.7       93.0  

Noncurrent liabilities:

    

Pension and postretirement healthcare benefits

     8.7       7.7  

Deferred tax liabilities

     28.3       18.8  

Other long-term liabilities

     12.4       11.9  
  

 

 

   

 

 

 

Total liabilities

     133.1       131.4  
  

 

 

   

 

 

 

Equity:

    

Net investment of Parent

     1,520.7       1,577.1  

Accumulated other comprehensive loss

     (3.2     (1.5
  

 

 

   

 

 

 

Total equity

     1,517.5       1,575.6  
  

 

 

   

 

 

 

Total liabilities and equity

   $ 1,650.6     $ 1,707.0  
  

 

 

   

 

 

 

The accompanying notes are an integral part of these Interim Condensed Combined Financial Statements.

 

4


Alkali Chemicals Business

(A Business of Tronox Limited)

INTERIM CONDENSED COMBINED STATEMENTS OF CHANGES IN PARENT COMPANY NET INVESTMENT (Unaudited)

(In millions)

 

     Net
investment of
parent
    Accumulated
other
comprehensive
income (loss)
    Total  

Balance at January 1, 2017

   $ 1,577.1     $ (1.5   $ 1,575.6  

Net income

     20.2       —         20.2  

Other comprehensive loss

     —         (1.7     (1.7

Net change in net investment of Parent

     (76.6     —         (76.6
  

 

 

   

 

 

   

 

 

 

Balance at June 30, 2017

   $ 1,520.7     $ (3.2   $ 1,517.5  
  

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these Interim Condensed Combined Financial Statements.

 

5


Alkali Chemicals Business

(A Business of Tronox Limited)

INTERIM CONDENSED COMBINED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

 

     Six months
ended
June 30, 2017
    Six months
ended
June 30, 2016
 

Cash Flows from Operating Activities:

    

Net Income

   $ 20.2     $ 14.9  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation, depletion and amortization

     32.5       29.3  

Reversal of bad debt expense

     (0.3     —    

Deferred income taxes

     10.4       7.7  

Share-based compensation expense

     1.0       0.5  

Pension expense

     2.7       2.4  

Contributions to employee pensions

     (1.8     (0.9

Changes in operating assets and liabilities:

    

Trade receivables

     1.0       (9.7

Receivables from related parties and affiliates, net

     6.7       2.1  

Inventories, net

     (1.6     2.1  

Prepaid and other assets

     1.9       1.8  

Accounts payable

     9.0       6.7  

Net due to Parent

     (8.6     (8.7

Accrued liabilities

     (6.5     1.1  

Pension and postretirement healthcare benefits

     0.2       0.1  

Other Long-term liabilities

     0.4       0.4  
  

 

 

   

 

 

 

Net cash provided by operating activities

     67.2       49.8  
  

 

 

   

 

 

 

Cash Flows from Investing Activities:

    

Capital expenditures

     (16.1     (20.3
  

 

 

   

 

 

 

Net cash used in investing activities

     (16.1     (20.3
  

 

 

   

 

 

 

Cash Flows from Financing Activities:

    

Net transfers to Parent

     (77.7     (41.6
  

 

 

   

 

 

 

Net cash used in financing activities

     (77.7     (41.6
  

 

 

   

 

 

 

Increase (decrease) in cash and cash equivalents

     (26.6     (12.1

Cash and cash equivalents at beginning of period

     37.2       33.7  
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 10.6     $ 21.6  
  

 

 

   

 

 

 

Supplemental Cash Flow Information:

    

Income taxes settled through Parent company equity

   $ 3.9     $ 2.8  

The accompanying notes are an integral part of these Interim Condensed Combined Financial Statements.

 

6


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

Note 1: Description of the Business

The accompanying unaudited interim condensed combined financial statements (“Interim Condensed Combined Financial Statements”) include the historical accounts of the Alkali Chemicals Business (collectively referred to as “Alkali”, “Tronox Alkali Ltd.”, “We”, “Us”, “Our” or the “Company”) of Tronox Limited (the “Parent” or “Tronox”), a public limited company registered under the laws of the State of Western Australia, Australia.

Nature of Operations

The Company mines and processes trona ore and manufactures natural soda ash and inorganic chemical products that include sodium bicarbonate, sodium sesquicarbonate and caustic soda (collectively referred to as “alkali products”). The alkali products are used in a variety of industries for glass manufacturing, water treatment, pulp and paper, textiles, food and pharmaceuticals and cosmetics. The alkali products are sold directly to various domestic and international customers as well as to the American Natural Soda Ash Corporation (“ANSAC”), the primary export customer of the Company. ANSAC is a third-party nonprofit corporation whose purpose is to promote export sales of U.S. produced soda ash in conformity with the Webb-Pomerene Act. All mining and processing activities of the Company take place at the facility located in the Green River Basin of Wyoming, United States. See Note 5 within these Interim Condensed Combined Financial Statements for additional information related to ANSAC.

Note 2: Basis of Presentation

Throughout the periods covered by the accompanying Interim Condensed Combined Financial Statements, Alkali operated as a business unit of Tronox. Consequently, standalone financial statements were not historically prepared for Alkali. The Interim Condensed Combined Financial Statements have therefore been derived from the accounting records of the Parent to present the Alkali historical carve-out interim condensed combined balance sheets as of June 30, 2017 and December 31, 2016; its results of operations for the three and six month periods ended June 30, 2017 and 2016; changes in Parent company net investment for the six months ended June 30, 2017 and cash flows for the six months ended June 30, 2017 and June 30, 2016.

The previously reported Interim Condensed Combined Statement of Cash Flows for the three months ended March 31, 2017 had an error in capital expenditures, which understated cash flows provided by operating activities and understated cash flows used in investing activities by $7.7. All capital expenditures included in accounts payable as of March 31, 2017 were paid as of June 30, 2017. As such, the statement of cash flows for the six months ended June 30, 2017 is appropriately presented. The Company evaluated the error considering both quantitative and qualitative factors and concluded it was not material to previously issued financial statements.

The Interim Condensed Combined Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information. The Interim Condensed Combined Financial Statements include the assets, liabilities, revenues and expenses of Alkali, as carved out from the historical results of operations and the historical bases of assets and liabilities of the Parent, adjusted to conform to U.S. GAAP. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These Interim Condensed Combined Financial Statements do not represent complete financial statements and should be read in conjunction with the Annual Combined Financial Statements for the years ended December 31, 2016 and 2015, collectively referred to as the “Annual Combined Financial Statements.”

As the Interim Condensed Combined Financial Statements present Alkali as a carve-out business derived from the historical records of the Parent, net investment of Parent is shown in lieu of shareholder’s equity on the Interim Condensed Combined Balance Sheets. With the exception of certain payables, intercompany

 

7


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

 

balances and transactions between Alkali and Tronox have been presented in Net investment of Parent. Intracompany balances and accounts within Alkali have been eliminated. Net investment of Parent represents Tronox’s interest in the recorded net assets of Alkali.

The Interim Condensed Combined Statements of Operations include all revenues and costs directly attributable to Alkali, as well as costs for certain functions and services used by Alkali. Therefore, certain costs related to Alkali have been allocated from the Parent. These allocated costs are primarily related to certain governance and corporate functions such as legal, investor relations, communications and administration. The costs associated with these services and support functions have been allocated to Alkali primarily through specific identification or a pro-rata allocation using net sales. The net costs allocated for these functions are included in Selling, general and administrative expenses within the Interim Condensed Combined Statements of Operations.

For purposes of the Interim Condensed Combined Financial Statements, the income tax expense and deferred tax balances have been estimated as if we filed income tax returns stand-alone basis separate from Tronox.

The Interim Condensed Combined Financial Statements of the Company do not present the Parent’s historical debt or related interest expense. The expense and cost allocations have been determined on a basis considered by management to be a reasonable reflection of the utilization of services both provided to and received by Alkali relative to the total costs incurred by Tronox. Additionally, the assets and liabilities assigned from Tronox have been deemed attributable to and reflective of the historical operations of Alkali. However, the amounts recorded may not be representative of the amounts that would have been incurred had Alkali been an entity that operated independently of Tronox. Consequently, the Interim Condensed Combined Financial Statements may not be indicative of Alkali’s future performance and do not necessarily reflect what its results of operations, financial position and cash flows would have been had Alkali operated as a separate entity apart from Tronox during the periods presented. See Note 5 for further discussion of cost allocations included in the Interim Condensed Combined Financial Statement.

Note 3: Summary of Significant Accounting Policies

Our significant accounting policies are those that we believe are important to the portrayal of our financial condition and results of operations, as well as those that involve significant judgments or estimates about matters that are inherently uncertain. There have been no material changes to the significant accounting policies as discussed in Note 3 of our Annual Combined Financial Statements.

Note 4: Recent Accounting Pronouncements

In addition to the accounting standards discussed in the Annual Combined Financial Statements, management assessed the impact of the following recently issued accounting standards:

In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting (“ASU 2017-09”), which clarifies when to account for a change to the terms or conditions of a share-based payment award as a modification. Under ASU 2017-09, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. ASU 2017-09 is effective prospectively for annual periods beginning on or after December 15, 2017, including interim periods within those periods. Early adoption is permitted. The impact, if any, that ASU 2017-09 will have on our Interim Condensed Combined Financial Statements will depend on any future award modification.

In March 2017, the FASB issued ASU 2017-07, Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (“ASU 2017-07”) which amends the requirements in ASC 715, Compensation - Retirement Benefits, which requires employers

 

8


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

 

that sponsor defined benefit pension and/or other postretirement plans to aggregate the various components of net periodic benefit cost for presentation purposes but does not prescribe where they should be presented in the income statement. ASU 2017-07 requires employers to present the service cost component of the net periodic benefit cost in the same income statement line item(s) as other employee compensation costs arising from service rendered during the period. In addition, only the service cost component will be eligible for capitalization in assets. Employers will present the other components separately from the line item(s) that includes the service cost and outside of any subtotal of operating income, if one is presented. Employers will have to disclose the line item(s) used to present the other components of net periodic benefit cost, if the components are not presented separately in the income statement. ASU 2017-07 is effective for fiscal years beginning after December 15, 2017, and interim periods within those years. Early adoption is permitted as of the beginning of an annual period for which an entity’s financial statements (interim or annual) have not been issued. ASU 2017-07 requires the presentation of the components of net periodic benefit cost in the income statement retrospectively while the guidance limiting the capitalization of net periodic benefit cost in assets to the service component will be applied prospectively. We have not yet determined the impact, if any, that ASU 2017-07 will have on our Interim Condensed Combined Financial Statements.

In March 2016, the FASB issued ASU 2016-05, Derivatives and Hedging: Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships (“ASU 2016-05”), which clarifies that a change in the counterparty to a derivative instrument that has been designated as the hedging instrument in an existing hedging relationship would not, in and of itself, be considered a termination of the derivative instrument or a change in a critical term of the hedging relationship. As long as all other hedge accounting criteria in ASC 815, Derivatives and Hedging (“ASC 815”) are met, a hedging relationship in which the hedging derivative instrument is novated would not be discontinued or require redesignation. This clarification applies to both cash flow and fair value hedging relationships. We adopted ASU 2016-05 during the first quarter of 2017. Its adoption did not have an impact on our Interim Condensed Combined Financial Statements.

In March 2016, the FASB issued Accounting Standards Update 2016-09, Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”), which amends ASC Topic 718, Compensation – Stock Compensation. ASU 2016-09 simplifies various aspects related to how share-based payments are accounted for and presented in the financial statements including income taxes and forfeitures of awards. We adopted ASU 2016-09 during the first quarter of 2017. Its adoption did not have a material impact on our Interim Condensed Combined Financial Statements.

In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”) which includes a lessee accounting model that recognizes two types of leases - finance leases and operating leases. The standard requires that a lessee recognize on the balance sheet assets and liabilities for leases with lease terms of more than 12 months. The recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee will depend on its classification as a finance or an operating lease. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition, and provides for certain practical expedients. Transition will require application of the new guidance at the beginning of the earliest comparative period presented. We have developed an implementation plan for adopting ASU 2016-02, which includes utilizing a software program to manage our lease obligations. We are evaluating the impact that ASU 2016-02 will have on our Interim Condensed Combined Financial Statements and have concluded that we will not early adopt ASU 2016-02.

In July 2015, as part of its simplification initiative, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory (“ASU 2015-11”). ASU 2015-11 simplifies the subsequent measurement of inventory by requiring entities to remeasure inventory at the lower of cost and net realizable value, which is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We adopted ASU 2015-11 during the first quarter of 2017. The adoption of ASU 2015-11 did not have an impact on our on our Interim Condensed Combined Financial Statements.

 

9


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

 

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) which states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires several new disclosures. This guidance is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted, and may be applied either retrospectively or on a modified retrospective basis. Subsequent to the issuance of the May 2014 guidance, several clarifications and updates have been issued on this topic, the most recent of which was issued in February 2017. We have developed an implementation plan for adopting ASU 2014-09 and are currently operating in line with that plan. We have completed our contract evaluation process and are currently validating the results of applying the new revenue guidance. We have also started documenting our accounting policies and evaluating the new disclosure requirements and we expect to complete the evaluation of the impact of the accounting and disclosure requirements on our business processes, controls and systems by the fourth quarter of 2017. We are evaluating the impact that ASU 2014-09 will have on our Interim Condensed Combined Financial Statements and expect to adopt the new standard using the modified retrospective approach effective January 1, 2018.

Note 5: Agreements and Transactions with Related Parties and Affiliates

Shared Services and Corporate Costs

We benefit from certain governance and corporate services provided by the Parent, including legal, investor relations, communications and administration. The amount of cost allocated to us by the Parent for these services was $4.6 and $4.7 for the three months ended June 30, 2017 and 2016, respectively and $9.5 and $9.0 for the six months ended June 30, 2017 and 2016, respectively. These Parent allocations were determined through either specific identification or a pro-rata allocation using net sales and are included within Selling, general and administrative expenses within the Interim Condensed Combined Statements of Operations.

Stock-Based Compensation

During the period, employees of the Company were eligible to participate in the Tronox Limited Management Equity Incentive Plan (the “MEIP”), which permits the grant of awards that are comprised of incentive options, nonqualified options, share appreciation rights, restricted shares, restricted share units, performance awards and other share-based awards, cash payments and other forms as the compensation committee of the Board of Directors of Tronox (the “Board”) in its discretion deems appropriate, including any combination of the above.

The Company recorded stock-compensation expense related to the MEIP of $0.6 and $0.4 for the three months ended June 30, 2017 and 2016, respectively and $1.1 and $0.5 for the six months ended June 30, 2017 and 2016, respectively. Stock compensation expense is included within in Selling, general and administrative expenses within the Interim Condensed Combined Statements of Operations.

Cash Management, Financing and Financial Instruments

Tronox uses a centralized approach to cash management and the financing of its operations. The available cash balances of Alkali are regularly “swept” at the discretion of Tronox with Tronox funding Alkali’s operating and investing activities as needed. Transfers and distributions of cash between Alkali and Tronox are included within Net investment of Parent on the Interim Condensed Combined Balance Sheets.

 

10


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

 

Agreements and Transactions with Affiliates

We hold a membership in ANSAC, which is responsible for promoting and increasing the use and sale of soda ash and other refined or processed sodium products produced. Costs incurred by ANSAC are charged directly to us and included within Selling, general and administrative expenses. These costs include sales and marketing, salaries, benefits, office supplies, professional fees, travel, rent and certain other costs. These transactions do not necessarily represent arm’s length transactions and may not represent all costs if we operated on a stand-alone basis. We also benefit from favorable shipping rates for our direct exports when using ANSAC to arrange for ocean transport. Net sales to ANSAC were $79.6 and $69.9 for the three months ended June 30, 2017 and June 30, 2016, respectively and $154.4 and $130.3 for the six months ended June 30, 2017 and 2016, respectively. The costs charged to us by ANSAC, included in Selling, general and administrative, were $1.5 and $1.8 for the three months ended June 30, 2017 and June 30, 2016, respectively and $2.1 and $4.4 for the six months ended June 30, 2017 and 2016, respectively.

Receivables from related parties and affiliates as of June 30, 2017 and December 31, 2016 are as follows:

 

     As of
June 30,
2017
     As of
December 31,
2016
 

NatronX Technologies LLC

   $ —        $ 0.1  

ANSAC

     53.3        59.9  
  

 

 

    

 

 

 

Total

   $ 53.3      $ 60.0  
  

 

 

    

 

 

 

Accounts payable from related parties and affiliates were $0.9 and $1.3 as of June 30, 2017 and December 31, 2016, respectively. These include related party payables to ANSAC which are included within Accounts payable on the Interim Condensed Combined Balance Sheets.

Note 6: Restructuring expense

In March 2017, the Company business announced a cost improvement initiative which focused on process improvements at our Wyoming facility (the “Wyoming Restructure”). During the first quarter of 2017, we recorded $1.2 to Restructuring expense in the Interim Condensed Combined Statements of Operations related to the Wyoming Restructure.

Note 7: Accounts Receivables, Net of Allowance for Doubtful Accounts

 

     As of
June 30,
2017
     As of
December 31,
2016
 

Trade receivables

   $ 71.7      $ 73.7  

Other

     13.5        12.5  

Allowance for doubtful accounts

     (1.0      (1.3
  

 

 

    

 

 

 

Total

   $ 84.2      $ 84.9  
  

 

 

    

 

 

 

 

11


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

 

Note 8: Inventories

 

     As of
June 30,
2017
     As of
December 31,
2016
 

Raw materials

   $ 3.9      $ 3.3  

Work-in-process

     4.9        5.9  

Finished goods, net

     14.9        16.3  

Materials and supplies, net

     11.6        8.2  
  

 

 

    

 

 

 

Total

   $ 35.3      $ 33.7  
  

 

 

    

 

 

 

Note 9: Prepaid and Other Current Assets

 

     As of
June 30,
2017
     As of
December 31,
2016
 

Prepaid royalty

   $ 3.9      $ 10.1  

Prepaid freight

     4.4        4.7  

Prepaid insurance

     3.3        1.1  

Prepaid longwall

     2.4        1.3  

Natural gas derivatives

     0.2        3.0  

Other

     0.5        0.6  
  

 

 

    

 

 

 

Total

   $ 14.7      $ 20.8  
  

 

 

    

 

 

 

Note 10: Property, Plant and Equipment, Net

 

     As of
June 30,
2017
     As of
December 31,
2016
 

Land and land improvements

   $ 68.1      $ 64.9  

Buildings

     70.9        71.4  

Mine and development costs

     7.0        7.0  

Machinery and equipment

     632.2        618.9  

Construction-in-progress

     57.7        63.0  
  

 

 

    

 

 

 

Total

     835.9        825.2  

Less: accumulated depreciation

     (114.2      (87.2
  

 

 

    

 

 

 

Total

   $ 721.7      $ 738.0  
  

 

 

    

 

 

 

Depreciation and amortization expense related to property, plant and equipment for the three months ended June 30, 2017 and 2016 was $14.2 and $13.3, respectively of which $14.2 and $13.3 was recorded in cost of goods sold for the three months ended June 30, 2017 and 2016, respectively in the Interim Condensed Combined Statements of Operations.

Depreciation and amortization expense related to property, plant and equipment for the six months ended June 30, 2017 and 2016 was $29.3 and $25.8, respectively of which $29.3 and $25.8 was recorded in cost of goods sold for the six months ended June 30, 2017 and 2016, respectively in the Interim Condensed Combined Statements of Operations.

 

12


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

 

Note 11: Mineral Leaseholds

 

     As of
June 30,
2017
     As of
December 31,
2016
 

Mineral leaseholds

   $ 738.5      $ 738.5  

Less accumulated depletion

     (11.9      (9.3
  

 

 

    

 

 

 

Total

   $ 726.6      $ 729.2  
  

 

 

    

 

 

 

Depletion expense related to mineral leaseholds for the three months ended June 30, 2017 and 2016 was $1.1 and $1.4, respectively and for the six months ending June 30, 2017 and 2016 was $2.6 and $2.6, respectively and was recorded in cost of goods sold in the Interim Condensed Combined Statements of Operations.

Note 12: Accrued Liabilities

 

     As of
June 30,
2017
     As of
December 31,
2016
 

Employee-related costs and benefits

   $ 14.1      $ 19.6  

Taxes other than income taxes

     7.4        7.6  

Accrued legal and professional expense

     1.1        1.8  

Other

     3.1        3.1  
  

 

 

    

 

 

 

Total

   $ 25.7      $ 32.1  
  

 

 

    

 

 

 

Note 13: Income Taxes

Alkali recorded income tax expense of $8.0 and $3.4 for the three months ended June 30, 2017 and 2016, respectively and $14.4 and $10.5 for the six months ending June 30, 2017 and 2016, respectively. The effective tax rate was 42.3% and 41.5% for the three months ended June 30, 2017 and 2016, respectively, and was 41.6% and 41.5% for the six months ending June 30, 2017 and 2016, respectively, and was higher than the statutory rate primarily due to state income taxes and changes in valuation allowance. Each year Alkali files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. These tax returns are subject to examination and possible challenge by the taxing authorities. Positions challenged by the taxing authorities may be settled or appealed by Alkali. As a result, income tax uncertainties are recognized in Alkali’s Interim Condensed Combined Financial Statements in accordance with accounting for income taxes, when applicable.

 

13


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

 

Note 14: Derivative Instruments

Alkali entered into futures contracts beginning in 2016 in order to mitigate exposure from changes in market prices related to certain natural gas prices. We mitigate our exposures to currency risks and commodity price risks, through a controlled program of risk management that includes the use of derivative financial instruments.

Alkali records these future contracts in either prepaid and other assets or other current liabilities at fair value in the Interim Condensed Combined Balance Sheets and recognizes changes in the fair value of these future contracts in accumulated other comprehensive income, as these instruments have been designated as cash flow hedges.

As of June 30, 2017, we were party to futures contracts with a notional value of $5.7, expiring in December, 2017. For the three months ended June 30, 2017 and 2016 and the six months ended June 30, 2017 and 2016, realized gains recorded within the Interim Condensed Combined Statement of Operations were immaterial. Unrealized losses on the future contracts amounted to $0.4 and $1.9 net of tax for the three months and six months ending June 30, 2017, respectively and was recorded in the Interim Condensed Combined Statements of Other Comprehensive Income. We expect to recognize this amount into earnings over the next 6 months.

The fair value of the natural gas commodity price contract was based on market price quotations and the use of a pricing model. The contract was considered a level 2 input in the fair value hierarchy at June 30, 2017 and December 31, 2016 and recorded in Prepaid and other assets and is further summarized below:

 

     Fair Value Measurement at June 30, 2017, Using:  
     Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
     Significant
Other
Observable
Inputs (Level 2)
     Significant
Unobservable
Inputs (Level 3)
     Total  

Asset Category:

           

Future Contracts

   $  —        $ 0.2      $  —        $ 0.2  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total at fair value

   $ —        $ 0.2      $ —        $ 0.2  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Fair Value Measurement at December 31, 2016, Using:  
     Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
     Significant
Other
Observable
Inputs (Level 2)
     Significant
Unobservable
Inputs (Level 3)
     Total  

Asset Category:

           

Future Contracts

   $ —        $  3.0      $ —        $  3.0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total at fair value

   $ —        $ 3.0      $ —        $ 3.0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Note 15: Commitments and Contingencies

Lease commitments

We lease various types of office space, manufacturing, data processing and rail transportation equipment. The gross rent expense under operating leases amounted to $4.2 and $4.3 for the three months ended June 30, 2017 and 2016, respectively and $8.5 and $8.7 for the six months ending June 30, 2017 and 2016, respectively.

 

14


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

 

At June 30, 2017, minimum rental commitments under non-cancelable operating leases were as follows:

 

Remainder of 2017

   $ 7.7  

2018

     15.1  

2019

     15.1  

2020

     15.3  

2021

     15.3  

Thereafter

     65.8  
  

 

 

 

Total

   $ 134.3  
  

 

 

 

Purchase commitments

The Company is party to coal supply contracts designed to mitigate volatility in the price of coal. The purchase commitments at June 30, 2017 were as follows:

 

Remainder of 2017

   $ 2.0  

2018

     4.1  

2019

     4.1  

2020

     4.1  

2021

     4.1  

Thereafter

     20.3  
  

 

 

 

Total

   $ 38.7  
  

 

 

 

Guarantees

Alkali together with other subsidiaries of the Parent, jointly and severally guarantee the Parent’s debt obligations, namely the UBS revolving credit facility having a maturity date no later than April 1, 2020, the Senior Notes due 2020 and the Senior Notes due 2022. The amount outstanding under these debt obligations was $896 and $584 at June 30, 2017.

Contingencies

We have certain contingent liabilities arising in the ordinary course of business. Some of these contingencies are known but are so preliminary that the merits cannot be determined, or if more advanced, are not deemed material based on current knowledge and some are unknown - for example, claims with respect to which we have no notice or claims which may arise in the future, resulting from products sold, guarantees or warranties made, or indemnities provided. Therefore, we are unable to develop a reasonable estimate of our potential exposure of loss for these contingencies, either individually or in the aggregate, at this time.

Based on information currently available and established reserves, we have no reason to believe that the ultimate resolution of known contingencies will have a material adverse effect on the combined financial position, liquidity or results of operations. However, there can be no assurance that the outcome of these contingencies will be favorable and adverse results in certain of these contingencies could have a material adverse effect on the combined financial position, results of operations in any one reporting period, or liquidity.

 

15


Alkali Chemicals Business

(A Business of Tronox Limited)

NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited)

(In millions)

 

Environmental

Portions of mining operations in the Green River Basin of Wyoming are powered by natural gas which is delivered to the site via pipelines. Condensate from a natural gas pipeline, that is no longer in service, was collected in a condensate tank and “blown-down” into an unlined condensate disposal pit, a practice that was widely accepted at the time. This condensate included contaminant traces of volatile organic compounds (“VOC”) that are characterized and monitored by the indicator parameter, benzene. As a result, site investigations have confirmed that these VOCs are present in the soils and groundwater which extends from the condensate disposal pit to a down-gradient area that is bounded by a groundwater cut-off wall and pump back system. Our Parent received notification from the WyDEQ requiring a Focused Feasibility Study (“FFS”) on the technologies that can be used to remedy the soils and groundwater in contaminated areas. The estimated cost for the FFS of $2.5 and $2.6 was included in other long-term liabilities in the Interim Condensed Combined Balance Sheets at June 30, 2017 and December 31, 2016.

Note 16: Subsequent Events

The Interim Condensed Combined Financial Statements have been derived from the consolidated financial statements of the Parent, which issued its interim financial statements for the period ended June 30, 2017 on August 9, 2017 and its annual financial statements for the periods ended December 31, 2016 and 2015 on February 24, 2017. Management has evaluated subsequent events through August 25, 2017 and recognized transactions in the Interim Condensed Combined Financial Statements as appropriate. Additionally, management has evaluated transactions that occurred as of the issuance date of these financial statements or August 25, 2017 for the purpose of disclosure of unrecognized events.

On August 2, 2017, the Parent entered into a definitive agreement to sell the Company to Genesis Energy, L.P. Under the terms of the agreement, the Parent will receive $1.325 billion in cash, subject to regulatory approval and customary closing conditions. The sale of the Company is expected to close September 1, 2017.

 

16

EXHIBIT 99.4

GENESIS ENERGY, L.P.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

TABLE OF CONTENTS

 

     Page  

INTRODUCTION TO PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     2  

PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET AS OF JUNE 30, 2017

     4  

PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 2017

     5  

PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 2016

     6  

Notes to Unaudited Pro Forma Condensed Consolidated Financial Statements

     7-10  

 

1


GENESIS ENERGY, L.P.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Introduction

The following Unaudited Pro Forma Condensed Consolidated Balance Sheet as of June 30, 2017 and the Unaudited Pro Forma Condensed Consolidated Statement of Operations for the year ended December 31, 2016 and the six months ended June 30, 2017 give effect to the acquisition (the “Acquisition”) by Genesis Energy, L.P. (“Genesis”) of the Alkali Business (the “Alkali Business”) of Tronox Limited (“Tronox”) for $1.325 billion and the related assumptions and adjustments described in the notes thereto. These statements will be referred to as the Unaudited Pro Forma Statements.

For purposes of preparing this data, the $1.325 billion of financing obtained by Genesis in connection with the Acquisition is based on net proceeds of $726.1 million as relating to a private placement of $750 million of our Series A convertible preferred units, gross proceeds of new indebtedness of approximately $550 million from the issuance of new senior unsecured notes and additional borrowings of $48.9 million under our senior secured credit facility. Such amounts do not include additional borrowings under our senior secured credit facility to finance estimated transaction costs to be incurred as a result of the Acquisition. See further discussion of such items in the accompanying footnotes.

As of the date of these Unaudited Pro Forma Statements, Genesis has not performed detailed valuation studies to determine the required estimates of the fair value of the Alkali Business assets to be acquired and the liabilities to be assumed or the required estimates of the fair value of certain provisions of our Series A Convertible Preferred Units. Accordingly, the pro forma adjustments for the Acquisition are preliminary and subject to further adjustments as additional information becomes available and the various analyses and other valuations are performed. Such adjustments may have a significant effect on total assets, total liabilities, total equity, operating expenses and depreciation and amortization expenses. The preliminary pro forma adjustments have been made solely for the purposes of providing the Unaudited Pro Forma Statements.

The Unaudited Pro Forma Statements are based upon the historical unaudited and audited financial statements of the Alkali Business, which are included in Exhibit 99.2 and Exhibit 99.3 in Genesis’ Current Report on Form 8-K filed on September 20, 2017, the unaudited condensed consolidated financial statements of Genesis for the six months ended June 30, 2017 as included in Genesis’ Form 10-Q, and the audited consolidated financial statements of Genesis for the year ended December 31, 2016 as included in Genesis’ Form 10-K for the fiscal year then ended. The Unaudited Pro Forma Statements have been compiled in a manner consistent with the accounting policies adopted by Genesis.

The Unaudited Pro Forma Statements of Genesis should be read in conjunction with the audited consolidated financial statements and notes thereto included in Genesis’ Annual Report on Form 10-K for the year ended December 31, 2016, the unaudited consolidated financial statements and notes thereto included in Genesis’ Quarterly Report on Form 10-Q for the six months ended June 30, 2017, and the audited and unaudited financial statements of the Alkali Business included in Exhibit 99.2 and Exhibit 99.3 in Genesis’ Current Report on Form 8-K filed on September 20, 2017.

The Unaudited Pro Forma Statements were prepared assuming that the acquisition by Genesis of the Alkali Business was consummated as of June 30, 2017 for the Unaudited Pro Forma Condensed Consolidated Balance Sheet and as of January 1, 2016 for the Unaudited Pro Forma Condensed Consolidated Statements of Operations. The Unaudited Pro Forma Statements have been prepared based upon assumptions deemed appropriate by Genesis and may not be indicative of actual results.

The historical consolidated financial information has been adjusted in the Unaudited Pro Forma Statements to give effect to pro forma events that are:

 

    directly attributable to the Acquisition;

 

    factually supportable; and

 

    with respect to the unaudited pro forma combined condensed statements of operations, expected to have a continuing impact on the combined results of Genesis and Alkali Business.

 

2


The Unaudited Pro Forma Statements do not reflect any cost savings (or associated costs to achieve such savings) from operating efficiencies or restructuring that could result from the Acquisition.

Assumptions and estimates underlying the unaudited pro forma combined condensed adjustments are described in the accompanying notes, which should be read in connection with the Unaudited Pro Forma Statements. Since the Unaudited Pro Forma Statements have been prepared in advance of the valuation to be used to allocate the purchase price, the final amounts recorded upon closing may differ materially from the information presented. These estimates are subject to change pending further review of the assets acquired and liabilities assumed and additional information available at the time of closing.

 

3


GENESIS ENERGY, L.P.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET

June 30, 2017

( in millions )

 

     Historical
Genesis
    Alkali
Business
    Pro Forma
Adjustments
          Pro Forma
Genesis
 

ASSETS

          

Cash and cash equivalents

   $ 10.1     $ 10.6     $ 550.0       (A)     $ 10.1  
         726.1       (A)    
         59.4       (A)    
         (1,335.6     (B)    
         (10.5     (C)    
         (9.8     (D)    
         9.8       (D)    

Accounts receivable—trade, net

     217.8       137.5           355.3  

Inventories

     68.8       35.3           104.1  

Other

     31.0       14.7           45.7  
  

 

 

   

 

 

   

 

 

     

 

 

 

Total current assets

     327.7       198.1       (10.6       515.2  

Fixed assets and mineral interests, net

     4,213.8       1,448.3       (206.0     (B)       5,456.1  

Investment in direct financing leases, net

     129.2       —             129.2  

Equity investees

     390.3       —             390.3  

Intangible assets, net

     193.4       —             193.4  

Goodwill

     325.0       —             325.0  

Other assets, net

     60.9       4.2       (4.2     (B)       60.9  
  

 

 

   

 

 

   

 

 

     

 

 

 

Total assets

   $ 5,640.3     $ 1,650.6     $ (220.8     $ 7,070.1  
  

 

 

   

 

 

   

 

 

     

 

 

 

LIABILITIES AND PARTNERS’ CAPITAL

          

Accounts payable—trade

   $ 117.1     $ 53.2         $ 170.3  

Accrued and other current liabilities

     120.1       30.5           150.6  
  

 

 

   

 

 

   

 

 

     

 

 

 

Total current liabilities

     237.2       83.7       0.0         320.9  

Senior secured credit facility

     1,211.0       —         69.2       (A)       1,280.2  

Senior unsecured notes

     1,816.3       —         550.0       (A)       2,356.5  
         (9.8     (D)    

Deferred tax liabilities

     26.2       28.3       (28.3     (B)       26.2  

Other long-term liabilities

     199.8       21.1           220.9  
  

 

 

   

 

 

   

 

 

     

 

 

 

Total liabilities

     3,490.5       133.1       581.1         4,204.7  
  

 

 

   

 

 

   

 

 

     

 

 

 

Mezzanine capital

          

Series A convertible preferred units

         726.1       (A)       726.1  

Partners’ capital:

          

Common unitholders

     2,159.7       1,520.7       (1,520.7     (B     2,149.2  
         (10.5     (C)    

Accumulated other comprehensive income

       (3.2     3.2       (B     0.0  

Noncontrolling Interest

     (9.9           (9.9
  

 

 

   

 

 

   

 

 

     

 

 

 

Total partners’ capital

     2,149.8       1,517.5       (1,528.0       2,139.3  
  

 

 

   

 

 

   

 

 

     

 

 

 

Total liabilities, mezzanine capital and partners’ capital

   $ 5,640.3     $ 1,650.6     $ (220.8     $ 7,070.1  
  

 

 

   

 

 

   

 

 

     

 

 

 

The accompanying notes are an integral part of these unaudited pro forma condensed consolidated financial statements.

 

4


GENESIS ENERGY, L.P.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

For the Six Months Ended June 30, 2017

(in millions, except per common unit amounts)

 

     Historical
Genesis
    Alkali
Business
    Pro Forma
Adjustments
          Pro Forma
Genesis
 

REVENUES

   $ 822.2     $ 391.9         $ 1,214.1  

COSTS AND EXPENSES:

          

Cost of sales and operating expenses

     602.9       304.2       5.6       (E)       912.7  

General and administrative expenses

     19.3       20.6       (5.6     (E)       34.3  

Depreciation, amortization and depletion expense

     112.7       32.5       (9.1     (F)       136.1  

Gain on sale of assets

     (26.7     —         —           (26.7
  

 

 

   

 

 

   

 

 

     

 

 

 

Total costs and expenses

     708.2       357.3       (9.1       1,056.4  
  

 

 

   

 

 

   

 

 

     

 

 

 

OPERATING INCOME

     114.0       34.6       9.1         157.7  

Equity in earnings of equity investees

     21.8       —         —           21.8  

Interest expense

     (74.7     —         (19.8     (G)       (94.5
  

 

 

   

 

 

   

 

 

     

 

 

 

Income before income taxes

     61.1       34.6       (10.7       85.0  

Income tax expense

     (0.6     (14.4     14.4       (H)       (0.6
  

 

 

   

 

 

   

 

 

     

 

 

 

NET INCOME

     60.5       20.2       3.7         84.4  

Net loss attributable to noncontrolling interest

     0.3       —             0.3  
  

 

 

   

 

 

   

 

 

     

 

 

 

NET INCOME ATTRIBUTABLE TO GENESIS

   $ 60.8     $ 20.2     $ 3.7       $ 84.7  
  

 

 

   

 

 

   

 

 

     

 

 

 

Net income attributable to Genesis per common unit:

          

Basic

   $ 0.50       $ (0.07     (I)     $ 0.44  

Diluted

   $ 0.50       $ (0.14     (I)     $ 0.37  

Weighted average common units:

          

Basic

     120.5             120.5  

Diluted

     120.5         22.2       (I)       142.7  

The accompanying notes are an integral part of these unaudited pro forma condensed consolidated financial statements.

 

5


GENESIS ENERGY, L.P.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

For the Twelve Months Ended December 31, 2016

(in millions, except per common unit amounts)

 

     Historical
Genesis
    Alkali
Business
    Pro Forma
Adjustments
          Pro Forma
Genesis
 

REVENUES

   $ 1,712.5     $ 785.8         $ 2,498.3  

COSTS AND EXPENSES:

          

Cost of sales and operating expenses

     1,238.3       612.0       10.8       (E)       1,861.1  

General and administrative expenses

     45.6       42.4       (10.8     (E)       77.2  

Depreciation, amortization and depletion expense

     222.2       60.4       (13.6     (F)       269.0  
  

 

 

   

 

 

   

 

 

     

 

 

 

Total costs and expenses

     1,506.1       714.8       (13.6       2,207.3  
  

 

 

   

 

 

   

 

 

     

 

 

 

OPERATING INCOME

     206.4       71.0       13.6         291.0  

Equity in earnings of equity investees

     47.9       —             47.9  

Interest expense

     (139.9     —         (39.6     (G)       (179.5

Other expense, net

     —         (1.5         (1.5
  

 

 

   

 

 

   

 

 

     

 

 

 

Income before income taxes

     114.4       69.5       (26.0       157.9  

Income tax expense

     (3.3     (28.8     28.8       (H)       (3.3
  

 

 

   

 

 

   

 

 

     

 

 

 

NET INCOME

     111.1       40.7       2.8         154.6  

Net loss attributable to noncontrolling interest

     2.1       —             2.1  
  

 

 

   

 

 

   

 

 

     

 

 

 

NET INCOME ATTRIBUTABLE TO GENESIS

   $ 113.2     $ 40.7     $ 2.8       $ 156.7  
  

 

 

   

 

 

   

 

 

     

 

 

 

Net income attributable to Genesis per common unit:

          

Basic

   $ 1.00       $ (0.20     (I)     $ 0.80  

Diluted

   $ 1.00       $ (0.33     (I)     $ 0.67  

Weighted average common units:

          

Basic

     113.4         —           113.4  

Diluted

     113.4         22.2       (I)       135.7  

The accompanying notes are an integral part of these unaudited pro forma condensed consolidated financial statements.

 

6


GENESIS ENERGY, L.P.

NOTES TO THE UNAUDITED PRO FORMA CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except where otherwise indicated, or amounts per unit)

 

  1. Basis of Pro Forma Presentation

The unaudited pro forma combined condensed financial information was prepared using the acquisition method of accounting and was based on the historical consolidated financial statements of Genesis Energy, L.P. (“Genesis) and the Alkali Business of Tronox Limited (“Alkali Business”) after giving effect to Genesis’ acquisition of the Alkali Business and related financing arrangements. All pro forma statements use Genesis’ period end date.

The allocation of the purchase price used in the Unaudited Pro Forma Statements is based on preliminary estimates of the fair value of assets acquired and liabilities assumed. Genesis expects the purchase price allocation to be completed upon the finalization of the related valuations and analyses. The final valuations may be materially different from the preliminary valuations. The pro forma adjustments included herein may be revised as additional information becomes available and as additional analyses and valuations are performed. The final allocation of the purchase price will be determined after completion of a final analysis to determine the fair values of the tangible assets, identifiable intangible assets, and liabilities as of the date the acquisition is complete, as well as the working capital as of the date of the acquisition. Accordingly, the final purchase accounting adjustments may be materially different from the pro forma adjustments presented in the Unaudited Pro Forma Statements. Increases or decreases in the fair value of the net assets may change the amount of the purchase price allocated to various assets and liabilities. This may impact the unaudited pro forma condensed consolidated statements of operations due to an increase or decrease in the amount of amortization or depreciation of the adjusted assets.

The acquisition method of accounting is based on Accounting Standards Codification, ASC, Topic 805, “Business Combinations,” and uses the fair value concepts defined in ASC Subtopic 820-10, “Fair Value Measurement.” ASC Topic 805 requires, among other things, that assets acquired and liabilities assumed be recognized at their fair values as of the Acquisition date.

ASC Subtopic 820-10 defines the term “fair value” and sets forth the valuation requirements for any asset or liability measured at fair value, expands related disclosure requirements and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined in ASC Subtopic 820-10 as ‘‘the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.” This is an exit price concept for the valuation of the asset or liability. In addition, market participants are assumed to be buyers and sellers in the principal (or the most advantageous) market for the asset or liability. Fair value measurements for an asset assume the highest and best use by these market participants. As a result of these standards, Genesis may be required to record assets that are not intended to be used or sold and/or to value assets at fair value measures that do not reflect Genesis’ intended use of those assets. Many of these fair value measurements can be highly subjective and it is also possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alternative estimated amounts.

Under the acquisition method of accounting, the assets acquired and liabilities assumed will be recorded as of the completion of the acquisition, at their respective fair values and consolidated with those of Genesis. Financial statements and reported results of operations of Genesis issued after completion of the acquisition will reflect these values. Periods prior to completion of the acquisition will not be retroactively restated to reflect the historical financial position or results of operations of the Alkali Business.

In addition, Genesis has not performed detailed valuation studies of the required estimates of the fair value of certain provisions of our Series A Convertible Preferred Units issued.

Under ASC Subtopic 805-10, transaction costs (e.g., advisory, legal, other professional fees) and certain restructuring charges impacting the target company are not included as a component of consideration transferred but are accounted for as expenses in the periods in which the costs are incurred. Total transaction costs incurred by Genesis are estimated to be $10.5 million.

 

7


The unaudited pro forma condensed financial statements are not intended to represent or be indicative of the consolidated results of operations or financial position of Genesis that would have been reported had the Acquisition been completed as of the dates presented, and should not be taken as representative of the future consolidated results of operations or financial position of Genesis. The unaudited pro forma condensed financial statements should be read in conjunction with Genesis financial statements for the six months ended June 30, 2017 and for the year ended December 31, 2016, which are included in its Annual Report on Form 10-K for the year ended December 31, 2017 and in Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2017. Alkali Business’s combined financial statements as of June 30, 2017, December 31, 2016 and 2015 and for the two years ended December 31, 2016, and for the six months ended June 30, 2017 and 2016 are included in Genesis’ Current Report on Form 8-K filed on September 20, 2017.

 

  2. Description of the Transaction

On August 3, 2017, we entered into a stock purchase agreement with a subsidiary of Tronox Limited pursuant to which we anticipated acquiring for approximately $1.325 billion in cash all of Tronox’s trona and trona-based exploring, mining, processing, producing, marketing and selling business through the acquisition of 100% of the equity interests in Alkali Business Corporation, another subsidiary of Tronox, on the terms and subject to the conditions set forth in the stock purchase agreement. We refer to that business as the “Alkali Business” and the acquisition of the Alkali Business as the “Alkali Business Acquisition”. The Alkali Business acquisition closed on September 1, 2017.

 

  3. Financing of the Transaction

These Unaudited Pro Forma Statements reflect Genesis’ acquisition of Alkali Business through a combination of the cash proceeds from the issuance of approximately $550 million of senior unsecured notes and net cash proceeds of approximately $726.1 million as relating to the issuance of our $750 million Series A Convertible Preferred Units (22,248,591 preferred units at an assumed offering price of $33.71 per preferred unit based on 110% of the volume weighted average of the last fifteen days closing price as of August 2, 2017 as per the preferred unit issuance agreement) of Genesis Energy, L.P. and $48.9 million from total additional borrowings under our under our senior secured credit facility. As relating to financing the $1.325 billion preliminary purchase price, these amount and these financing assumptions include the purchase of estimated net working capital reflected in the financial statements of the Alkali Business which we assumed to be the same at closing. These amounts also include additional borrowings under our senior secured credit facility to finance a portion of our transaction related costs incurred. All associated fees related to the acquisition of the Alkali Business and the issuance of long term debt and equity have been reflected in the pro forma financial statements. A summary of assumed financing related items resulting from the Acquisition is shown below:

 

Financing Item

   Amount
(in
millions)
 

Net Proceeds from Issuance of Series A Convertible Preferred Units

   $ 726.1  

Gross Proceeds from Issuance of Senior Unsecured Notes

     550.0  

Additional Borrowings Under Senior Secured Credit Facility to Finance Base Purchase Price, inclusive of Working Capital

     48.9  

Additional Borrowings Under Senior Secured Credit Facility to Finance Note Issuance and Credit Facility Related Costs

     9.8  

Additional Borrowings Under Senior Secured Credit Facility to Finance Other Transaction and Financing Related Costs

     10.5  
  

 

 

 

Total Proceeds

   $ 1,345.3  
  

 

 

 

 

8


  4. Estimate of Assets Acquired and Liabilities Assumed

The preliminary estimate of the fair values of assets acquired and liabilities assumed as of the closing of the Acquisition were allocated to each of Alkali Business’s assets and liabilities, pending Genesis’s completion of its purchase price allocation after closing once final analyses and valuations can be completed. Genesis cannot currently estimate the value of the purchase price to be allocated to property, plant and equipment, goodwill or identifiable intangible assets at this time. As a result, for purposes of this pro forma presentation, the net of the purchase price in excess of estimated preliminary fair value assigned to mineral leaseholds and other long-term assets has been reflected in property, plant and equipment. Working capital (related to current assets and current liabilities to be assumed) has been assigned to the appropriate balance sheet accounts. The results of final analyses and valuations may reflect a value for certain customer contracts or other identifiable intangible assets, the quantification of which cannot be determined at this time.

The preliminary estimates of fair values of assets acquired and liabilities assumed (in millions) are as follows :

 

     Amount
Allocated

(in millions)
 

Accounts Receivable

   $ 137.5  

Inventories

     35.3  

Other Current Assets

     14.7  

PPE and Mineral Interests

     1,242.3  

Accounts Payable

     (53.2

Accrued Liabilities and other current liabilties

     (30.5

Other Long-term Liabilities

     (21.1
  

 

 

 

Net Purchase Price

   $ 1,325.0  
  

 

 

 

The $1,242.3 million assigned to Property, Plant, and Equipment and Mineral Interests is estimated to be attributed to mineral leaseholds, land, buildings, machinery and equipment. An estimated average useful life of 15 years has been used for purposes of calculating estimated depreciation expense and approximately 100 years for purposes of calculating estimated depletion expense in these Unaudited Pro Forma Statements.

 

  5. Adjustments to Unaudited Pro Forma Statements

(A) Reflects the financing of the Alkali Business Acquisition. As previously mentioned, this includes net cash proceeds of approximately $726.1 million relating to the issuance of our $750 million Series A Convertible Preferred Units (22,248,591 preferred units at an assumed offering price of $33.71 per preferred unit based on 110% of the volume weighted average of the last fifteen days closing price as of August 2, 2017 as per the preferred unit issuance agreement), $550 million of new senior unsecured notes, and $59.4 million of incremental borrowings under our senior secured credit facility. In addition to financing the $1.325 billion preliminary purchase price, these financing assumptions also include additional borrowings under our credit facility to finance a portion of our transaction related costs assumed to be incurred.

(B) Reflects the effects of the preliminary purchase price allocation relating to the Acquisition. This adjustment also reflects the removal of previously recorded deferred tax liabilities and parent company equity as recorded in the historic balance sheet of the Alkali Business as of June 30, 2017 prior to applying the preliminary purchase price allocation. See Note 4 for further discussion surrounding the preliminary purchase price allocation.

(C) Reflects the estimated amounts relating to one-time transaction costs for various services and other payments necessary to complete the Acquisition.

(D) Reflects estimated new deferred debt issuance costs for the $550 million issuance of senior unsecured notes to finance a portion of the Acquisition. Such items include legal fees, underwriting fees, bank fees and other services which would be amortized over the term of the notes and credit agreement respectively.

 

9


(E) Reflects the reclassification of selling expenses relating to the Alkali Business to provide for consistency with Genesis’s historical presentation.

(F) Reflects change in depreciation, as well as the addition of depletion expense, resulting from the change in fair value and lives of tangible assets and mineral interests acquired from Alkali Business resulting from the preliminary purchase price allocation.

(G) Reflects increase in interest expense resulting from the issuance of $550 million in senior unsecured notes and incremental borrowings of $69.2 million under our senior secured credit facility resulting from the financing of this Acquisition and associated costs. Interest expense on the notes is calculated at an assumed annual interest rate of 6.5%. Interest expense on the incremental borrowing under our senior secured credit facility is calculated at an assumed annual interest rate of 3.0% (an approximation of Genesis’ historic rate on LIBOR borrowing under its credit facility). This adjustment also reflects additional amortization of debt issuance costs related to the new senior unsecured note issuance. A 0.125% increase or decrease to the assumed interest rate on the borrowings would increase or decrease pro forma interest expense by approximately $1.2 million on an annual basis and $0.3 million on a quarterly basis.

(H) Reflects the reversal of income tax expense recorded by the Alkali business as a result of the tax treatment when included in Genesis’s taxable structure.

(I) Reflects change in weighted average diluted common units from the issuance of Series A Convertible Preferred Units (22,248,591 preferred units at an assumed offering price of $33.71 per preferred unit based on 110% of the volume weighted average of the last fifteen days closing price as of August 2, 2017 as per the preferred unit issuance agreement) to finance a portion of this Acquisition. In addition, this reflects the change in basic and diluted net income attributable to common unitholders per common unit as a result of assumed distributions to preferred unitholders over the corresponding periods in determining income available to common unitholders.

 

10